or Try an Advanced Search...

    Technical Analysis for FBRX - Forte Biosciences, Inc.

    Grade Last Price % Change Price Change
    B 13.55 128.69% 7.62
    FBRX closed up 128.69 percent on Wednesday, November 20, 2024, on 49.02 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical FBRX trend table...
    Date Alert Name Type % Chg
    Crossed Above 200 DMA Bullish 0.00%
    Expansion Breakout Bullish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Wide Range Bar Range Expansion 0.00%
    Parabolic Rise Strength 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Multiple of Ten Bullish Other 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Older End-of-Day Signals for FBRX ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 19 hours ago
    Rose Above 200 DMA about 19 hours ago
    2x Volume Pace about 20 hours ago
    1.5x Volume Pace about 20 hours ago
    3x Volume Pace about 20 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    FBRX Chart by TradingView
    Basic chart:

    Profile

    Forte Biosciences, Inc. is a clinical stage, dermatology company developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric (3 years of age and older) patients with atopic dermatitis. There is a significant unmet need for safe and effective therapies particularly for pediatric atopic dermatitis patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Monoclonal Antibodies Dermatology Atopic Dermatitis Dermatitis Skin Diseases Type I Hypersensitivity Atopy Sodium Hypochlorite Washes

    Is FBRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
    Nov 20 Forte Biosciences announces oversubscribed $53 million private placement
    Nov 20 Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
    Nov 15 Forte Biosciences GAAP EPS of -$4.54
    Nov 14 Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
    Aug 26 Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested
    Aug 14 Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
    May 21 Companies Like Forte Biosciences (NASDAQ:FBRX) Could Be Quite Risky
    May 17 Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
    See more FBRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.25
    52 Week Low 4.11
    Average Volume 603,564
    200-Day Moving Average 12.42
    50-Day Moving Average 5.57
    20-Day Moving Average 5.46
    10-Day Moving Average 6.37
    Average True Range 1.32
    RSI (14) 91.64
    ADX 43.8
    +DI 78.85
    -DI 4.05
    Chandelier Exit (Long, 3 ATRs) 14.85
    Chandelier Exit (Short, 3 ATRs) 8.07
    Upper Bollinger Bands 9.34
    Lower Bollinger Band 1.58
    Percent B (%b) 1.54
    BandWidth 142.06
    MACD Line 0.79
    MACD Signal Line 0.11
    MACD Histogram 0.6719
    Fundamentals Value
    Market Cap 492.34 Million
    Num Shares 36.3 Million
    EPS -1.20
    Price-to-Earnings (P/E) Ratio -11.29
    Price-to-Sales 0.00
    Price-to-Book 0.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 28.58
    Resistance 3 (R3) 28.66 23.74 26.07
    Resistance 2 (R2) 23.74 19.91 23.69 25.24
    Resistance 1 (R1) 18.64 17.54 21.19 18.56 24.40
    Pivot Point 13.72 13.72 14.99 13.68 13.72
    Support 1 (S1) 8.62 9.89 11.17 8.54 2.70
    Support 2 (S2) 3.70 7.53 3.66 1.86
    Support 3 (S3) -1.39 3.70 1.03
    Support 4 (S4) -1.48